ORTEXORTEX News
Tracking CTSH? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CT
ConfluenceCTSH

CTSH shorts cover fast as earnings loom July 29

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 27 Jul 2026, 13:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of Cognizant Technology Solutions Corporation (CTSH) share price and short interest (% of free float), three months to July 24, 2026
ORTEX data as of 27 Jul 2026, 13:03

Short sellers have cut their CTSH position by 15.2% in a single week. The stock gained 5.7% in the same period. With earnings due July 29, options traders are leaning bullish — but analysts keep trimming targets.

Shorts Bail Ahead of Results

Short interest fell to 11.4% of free float as of July 24, down from roughly 13.5% a week earlier. That is a drop of more than 7.7 million shares in five trading days. The covering accelerated as the stock bounced off multi-month lows.

The borrow market remains well-supplied. Availability sits at 595% — roughly six shares available for every one currently borrowed. Cost to borrow is just 0.40%, well below levels that would signal any stress in the lending pool. Shorts exiting now face no squeeze mechanics; this looks like discretionary de-risking ahead of a binary event.

Options Traders Turned Bullish Mid-Week

Earlier this week, the put-call ratio dropped to 0.997–1.005, nearly 2.7 standard deviations below the 20-day mean of around 1.11. That is an unusual signal for a stock whose PCR typically runs above 1.1. By July 24 the PCR had drifted back to 1.14, roughly in line with the recent average, suggesting the burst of call buying was a short-term positioning move rather than a structural shift.

The pattern fits the pre-earnings playbook. Traders buying calls while shorts cover creates a one-directional flow in the days before a report.

Analysts Cut Targets, Hold Ratings

The analyst picture is more cautious. Multiple firms slashed price targets this week after CTSH's Q2 update. JP Morgan cut its target from $74 to $55 while keeping Overweight. RBC dropped from $88 to $47 at Sector Perform. Guggenheim lowered from $80 to $65 at Buy.

The consensus mean target stands at $60.38 — a 33% premium to the current price of $45.45. That gap is wide. But every recent revision has been downward, and the string of cuts began well before earnings, suggesting analysts were already repositioning for a weaker demand environment.

The bear case centers on pricing pressure, integration risk from acquisitions, and softer discretionary IT budgets among financial services clients. The bull case rests on the Astreya acquisition, the AI Factory initiative, and strong hyperscaler relationships.

What to Watch

Earnings on July 29 are the immediate catalyst. The last two quarterly reports produced one-day drops of 4% and 6.4% respectively. The combination of short covering and pre-earnings call buying suggests the market is positioned for a better outcome this time — but the analyst target cuts tell a different story.

  • SI % of FF: 11.4%, down from 13.5% one week ago
  • Short shares covered in 1 week: ~9.7 million
  • Availability: 595% (loose borrow market)
  • Cost to borrow: 0.40%
  • PCR: 1.14 (20-day mean: 1.11)
  • Consensus price target: $60.38 vs. current price $45.45
  • Next earnings: July 29, 2026

Against its own history

This week's change in short interest is 1.7 standard deviations below the company's typical weekly move over the past year.

Against its peers

Shares moved +1.5% over the past week against a median of -0.2% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open CTSH on ORTEX →

How this article was generated

Generated
27 Jul 2026, 13:06
Data as of
27 Jul 2026, 13:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.